ACON
Aclarion, Inc.
1W: -3.9%
1M: +25.0%
3M: -45.8%
YTD: -35.7%
1Y: -84.3%
3Y: -100.0%
$3.20
-0.06 (-1.84%)
After Hours: $3.25 (+0.04, +1.41%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.9M
52W Range2.34-21.33
Volume62,946
Avg Volume896,569
Beta1.44
Dividend—
Analyst Ratings
Company Info
CEOBrent Ness
Employees5
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2022-04-22
Websiteaclarion.com
951 Mariners Island Boulevard
Broomfield, CA 94404
US
Broomfield, CA 94404
US
650-241-1741
About Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Latest News
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
Aclarion (NASDAQ:ACON) & InnovAge (NASDAQ:INNV) Head-To-Head Comparison
Aclarion Publishes 2026 Shareholder Letter from the Chairman
Aclarion Publishes 2026 Shareholder Letter from the Chairman
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Ness Brent | P-Purchase | 10 | $6.20 | 2025-11-26 |
| Gould Gregory A | A-Award | 17,000 | $7.15 | 2025-09-02 |
| Gould Gregory A | 0 | — | 2025-09-02 | |
| Thramann Jeffrey Joh | J-Other | 1 | $1,000.00 | 2023-03-28 |
| Thramann Jeffrey Joh | P-Purchase | 1 | $1,000.00 | 2023-02-16 |